PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Phathom Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$7.01+0.09 (+1.30%)
Close on Oct 19, 2026
- Market cap
- $587.07M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
89.1%
72M of 81M shares
Institutional holders
162
22 new, 32 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $7.08K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Limited | 7,464,572 | 13.00% | 13G (passive) amendment | Jan 24, 2024 |
| James N. Topper | 5,985,327 | 8.60% | 13D (active) amendment | Nov 1, 2025 |
| BlackRock, Inc. | 4,378,647 | 5.50% | 13G (passive) | Jun 30, 2026 |
| Millennium Group Management LLC | 4,178,411 | 5.30% | 13G (passive) | Mar 6, 2026 |
| Invesco Ltd. | 3,167,653 | 5.50% | 13G (passive) amendment | Dec 29, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PHAT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 12,466,489 | 15.41% | $135.26M | – | 2.95% |
| Medicxi Ventures Management (Jersey) Ltd | 7,464,572 | 9.23% | $80.99M | – | 45.65% |
| BlackRock, Inc. | 4,525,129 | 5.59% | $49.10M | +463,133 | 0.00% |
| Invesco Ltd. | 4,029,731 | 4.98% | $43.72M | −292,329 | 0.00% |
| Carlyle Group Inc. | 3,496,808 | 4.32% | $37.94M | – | 0.38% |
| Millennium Management LLC | 3,375,834 | 4.17% | $36.63M | −647,075 | 0.01% |
| Vanguard Capital Management LLC | 2,656,944 | 3.28% | $28.83M | +73,308 | 0.00% |
| GW&K Investment Management, LLC | 2,166,838 | 2.68% | $23.51K | +745,729 | 0.18% |
| Franklin Resources Inc | 1,970,828 | 2.44% | $21.38M | +976,324 | 0.00% |
| NEA Management Company, LLC | 1,960,169 | 2.42% | $21.27M | – | 1.34% |
| 683 Capital Management, LLC | 1,850,000 | 2.29% | $20.07M | – | 0.99% |
| Goldman Sachs Group Inc | 1,778,032 | 2.20% | $19.29M | +1,151,836 | 0.00% |
| State Street Corp | 1,586,323 | 1.96% | $17.21M | +199,433 | 0.00% |
| Catalys Pacific, LLC | 1,493,854 | 1.85% | $16.21M | – | 7.06% |
| Nomura Asset Management International Inc. | 1,462,738 | 1.81% | $15.87M | +257,369 | 0.02% |
| Geode Capital Management, LLC | 1,315,687 | 1.63% | $14.28M | −12,358 | 0.00% |
| Wasatch Advisors LP | 1,307,247 | 1.62% | $14.18M | −33,669 | 0.09% |
| Ensign Peak Advisors, Inc | 1,051,913 | 1.30% | $11.41M | −575,893 | 0.02% |
| Propel Bio Management, LLC | 1,050,358 | 1.30% | $11.40M | +209,086 | 5.96% |
| Point72 Asset Management, L.P. | 1,022,193 | 1.26% | $11.09M | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 162 | 72M | 89.1% | 22 / 59 | 50 / 32 | 8M | 5M |
| Q1 2026 | 174 | 69M | 85.5% | 37 / 75 | 40 / 35 | 16M | 5M |
| Q4 2025 | 173 | 62M | 76.6% | 50 / 49 | 50 / 10 | 6M | 6M |
| Q3 2025 | 133 | 62M | 77.2% | 27 / 45 | 28 / 11 | 8M | 3M |
| Q2 2025 | 117 | 58M | 71.2% | 17 / 42 | 38 / 36 | 8M | 15M |
| Q1 2025 | 137 | 64M | 79.2% | 25 / 48 | 35 / 31 | 5M | 7M |
| Q4 2024 | 144 | 67M | 82.4% | 36 / 59 | 27 / 22 | 8M | 14M |
| Q3 2024 | 133 | 73M | 90.0% | 30 / 57 | 18 / 10 | 21M | 3M |
| Q2 2024 | 114 | 58M | 72.0% | 18 / 48 | 21 / 17 | 6M | 4M |
| Q1 2024 | 114 | 56M | 69.2% | 13 / 41 | 34 / 16 | 9M | 7M |
| Q4 2023 | 117 | 54M | 67.2% | 25 / 50 | 22 / 17 | 14M | 3M |
| Q3 2023 | 110 | 44M | 54.1% | 15 / 48 | 24 / 7 | 3M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PHAT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Invesco Global Fund | 2,342,451 | 2.90% | $20.50M | 0.23% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 2,007,668 | 2.48% | $21.78M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,279,319 | 1.58% | $13.88M | 0.02% | Jun 30, 2026 |
| Nomura Small Cap Growth Fund | 988,514 | 1.22% | $10.73M | 0.92% | Jun 30, 2026 |
| Strategic Advisers U.S. Total Stock Fund | 966,287 | 1.19% | $9.27M | 0.01% | May 31, 2026 |
| Franklin Small Cap Growth Fund | 827,068 | 1.02% | $7.24M | 0.29% | Jul 31, 2026 |
| Wasatch Micro Cap Fund | 806,558 | 1.00% | $8.75M | 1.30% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 586,632 | 0.73% | $6.36M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 536,038 | 0.66% | $4.69M | 0.01% | Jul 31, 2026 |
| Franklin Biotechnology Discovery Fund | 507,425 | 0.63% | $4.44M | 0.38% | Jul 31, 2026 |
| Wasatch Ultra Growth Fund | 461,876 | 0.57% | $5.01M | 1.09% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF | 419,786 | 0.52% | $4.55M | 1.06% | Jun 30, 2026 |
| iShares Biotechnology ETF | 401,413 | 0.50% | $4.36M | 0.05% | Jun 30, 2026 |
| Invesco V.I. Global Fund | 356,195 | 0.44% | $3.86M | 0.28% | Jun 30, 2026 |
| JNL/Invesco Global Growth Fund | 337,376 | 0.42% | $3.75M | 0.32% | Mar 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Steven L. Basta | President and CEO, Director | 373,315 | 0.46% | Feb 12, 2026 |
| Terrie Curran | President and Chief Executive, Director | 364,305 | 0.45% | Mar 3, 2025 |
| Robert Charles Breedlove | Principal Accounting Officer | 67,657 | 0.08% | Sep 8, 2026 |
| Anne Marie Cook | Chief Legal Off. & Corp. Sec. | 88,660 | 0.11% | Feb 12, 2026 |
| Sanjeev Narula | Chief Financial & Bus. Officer | 226,715 | 0.28% | Jan 2, 2026 |
| Molly Henderson | CFO and CBO | 91,779 | 0.11% | Apr 8, 2025 |
| Azmi Nabulsi | Chief Operating Officer | 1,101,869 | 1.36% | Mar 3, 2025 |
| Asit Parikh | Director | 172,622 | 0.21% | May 27, 2026 |
| Mark Stenhouse | Director | 54,122 | 0.07% | May 21, 2026 |
| Frank Karbe | Director | 91,622 | 0.11% | May 21, 2026 |
| James N. Topper | Director, 10% owner | 5,957,449 | 7.36% | May 21, 2026 |
| Michael F. Cola | Director | 63,920 | 0.08% | May 21, 2026 |
| Theodore R. Schroeder | Director | 45,122 | 0.06% | May 21, 2026 |
| Heidi Fields | Director | 54,122 | 0.07% | May 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert Charles Breedlove Principal Accounting Officer | Sep 3, 2026 | Tax withholding | −460 | $9.05 | $4.16K | 59,465 |
| Robert Charles Breedlove Principal Accounting Officer | Jul 14, 2026 | Tax withholding | −1,555 | $11.04 | $17.17K | 59,925 |
| Asit Parikh Director | May 22, 2026 | Gift | −28,000 | – | – | 24,122 |
| Asit Parikh Director | May 22, 2026 | Gift | +28,000 | – | – | 148,500 |
| Asit Parikh Director | May 20, 2026 | Option exercise | +17,500 | $4.95 | $86.63K | 52,122 |
| Frank Karbe Director | May 19, 2026 | Award | +24,122 | – | – | 91,622 |
| Theodore R. Schroeder Director | May 19, 2026 | Award | +24,122 | – | – | 45,122 |
| Mark Stenhouse Director | May 19, 2026 | Award | +24,122 | – | – | 54,122 |
| James N. Topper Director, 10% owner | May 19, 2026 | Award | +24,122 | – | – | 66,718 |
| Asit Parikh Director | May 19, 2026 | Award | +24,122 | – | – | 34,622 |
| Heidi Fields Director | May 19, 2026 | Award | +24,122 | – | – | 54,122 |
| Michael F. Cola Director | May 19, 2026 | Award | +24,122 | – | – | 63,920 |
| Asit Parikh Director | Mar 10, 2026 | Gift | −40,000 | – | – | 10,500 |
| Asit Parikh Director | Mar 10, 2026 | Gift | +40,000 | – | – | 120,500 |
| Robert Charles Breedlove Principal Accounting Officer | Feb 27, 2026 | Tax withholding | −414 | $12.56 | $5.20K | 61,480 |
| Robert Charles Breedlove Principal Accounting Officer | Feb 27, 2026 | Tax withholding | −964 | $12.56 | $12.11K | 61,894 |
| Robert Charles Breedlove Principal Accounting Officer | Feb 27, 2026 | Award | +2,790 | – | – | 62,858 |
| Robert Charles Breedlove Principal Accounting Officer | Feb 27, 2026 | Award | +13,000 | – | – | 60,068 |
| Steven L. Basta President and CEO, Director | Feb 10, 2026 | Tax withholding | −6,277 | $12.82 | $80.47K | 373,315 |
| Steven L. Basta President and CEO, Director | Feb 10, 2026 | Award | +12,362 | – | – | 379,592 |
| Anne Marie Cook Chief Legal Off. & Corp. Sec. | Feb 10, 2026 | Tax withholding | −1,535 | $12.82 | $19.68K | 88,660 |
| Anne Marie Cook Chief Legal Off. & Corp. Sec. | Feb 10, 2026 | Award | +3,461 | – | – | 90,195 |
| Asit Parikh Director | Jan 23, 2026 | Gift | +80,500 | – | – | 80,500 |
| Asit Parikh Director | Jan 23, 2026 | Gift | −80,500 | – | – | 50,500 |
| Robert Charles Breedlove Principal Accounting Officer | Jan 21, 2026 | Tax withholding | −776 | $13.61 | $10.56K | 47,068 |
| Asit Parikh Director | Jan 13, 2026 | Option exercise | +8,750 | $10.30 | $90.13K | 131,000 |
| Steven L. Basta President and CEO, Director | Jan 2, 2026 | Award | +251,034 | – | – | 364,820 |
| Sanjeev Narula Chief Financial & Bus. Officer | Jan 2, 2026 | Award | +82,715 | – | – | 226,715 |
| Anne Marie Cook Chief Legal Off. & Corp. Sec. | Jan 2, 2026 | Award | +75,345 | – | – | 85,012 |
| Asit Parikh Director | Dec 19, 2025 | Option exercise | +8,750 | $10.30 | $90.13K | 122,250 |
| Robert Charles Breedlove Principal Accounting Officer | Dec 18, 2025 | Tax withholding | −230 | $16.28 | $3.74K | 47,844 |
| Anne Marie Cook Chief Legal Off. & Corp. Sec. | Dec 17, 2025 | Award | +17,370 | – | – | 17,370 |
| Anne Marie Cook Chief Legal Off. & Corp. Sec. | Dec 17, 2025 | Tax withholding | −7,703 | $15.36 | $118.32K | 9,667 |
| Steven L. Basta President and CEO, Director | Dec 17, 2025 | Award | +62,038 | – | – | 145,288 |
| Steven L. Basta President and CEO, Director | Dec 17, 2025 | Tax withholding | −31,502 | $15.36 | $483.87K | 113,786 |
| Steven L. Basta President and CEO, Director | Nov 28, 2025 | Option exercise | +90,000 | – | – | 131,625 |
| Steven L. Basta President and CEO, Director | Nov 28, 2025 | Tax withholding | −48,375 | $15.62 | $755.62K | 83,250 |
| Robert Charles Breedlove Principal Accounting Officer | Nov 3, 2025 | Sale | −524 | $13.51 | $7.08K | 47,407 |
| Sanjeev Narula Chief Financial & Bus. Officer | Oct 6, 2025 | Award | +144,000 | – | – | 144,000 |
| Steven L. Basta President and CEO, Director | Sep 25, 2025 | Tax withholding | −48,375 | $11.66 | $564.05K | 41,625 |
| Steven L. Basta President and CEO, Director | Sep 25, 2025 | Option exercise | +90,000 | – | – | 90,000 |
| Robert Charles Breedlove Principal Accounting Officer | Sep 5, 2025 | Sale | −461 | $12.09 | $5.57K | 47,931 |
| Robert Charles Breedlove Principal Accounting Officer | Jul 16, 2025 | Sale | −1,692 | $8.36 | $14.15K | 48,392 |
| Michael F. Cola Director | Jun 3, 2025 | Award | +10,500 | – | – | 39,798 |
| Asit Parikh Director | Jun 3, 2025 | Award | +10,500 | – | – | 113,500 |
| James N. Topper Director, 10% owner | Jun 3, 2025 | Award | +10,500 | – | – | 42,596 |
| Heidi Fields Director | Jun 3, 2025 | Award | +10,500 | – | – | 30,000 |
| Mark Stenhouse Director | Jun 3, 2025 | Award | +10,500 | – | – | 30,000 |
| Frank Karbe Director | Jun 3, 2025 | Award | +10,500 | – | – | 67,500 |
| James N. Topper Director | May 21, 2025 | Buy | +3,780 | $3.86 | $14.59K | 59,403 |
| James N. Topper Director | May 14, 2025 | Buy | +6,300 | $3.32 | $20.92K | 55,623 |
| James N. Topper Director | May 13, 2025 | Buy | +1,120 | $3.16 | $3.54K | 49,323 |
| James N. Topper Director | May 12, 2025 | Buy | +12,601 | $3.04 | $38.31K | 48,203 |
| James N. Topper Director | May 9, 2025 | Buy | +33,376 | $3.19 | $106.47K | 33,376 |
| James N. Topper Director | May 9, 2025 | Buy | +2,226 | $3.62 | $8.06K | 35,602 |
| Asit Parikh Director | May 7, 2025 | Buy | +5,000 | $2.40 | $12.00K | 95,500 |
| Asit Parikh Director | May 6, 2025 | Buy | +5,000 | $2.60 | $13.00K | 90,500 |
| Theodore R. Schroeder Director | Apr 16, 2025 | Award | +21,000 | – | – | 21,000 |
| Molly Henderson CFO and CBO | Apr 7, 2025 | Sale | −3,678 | $4.55 | $16.73K | 89,868 |
| Asit Parikh Director | Mar 13, 2025 | Buy | +10,000 | $4.42 | $44.20K | 85,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.